Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.

MLA

Johnson, Linda S., et al. “Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.” Journal of the American Heart Association, vol. 13, no. 17, Sept. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1161/JAHA.123.034758.

APA

Johnson, L. S., Benz, A. P., Shoamanesh, A., Eikelboom, J. W., Ezekowitz, M., Giugliano, R. P., Wallentin, L., Ruff, C. T., Lopes, R. D., Jolly, S., Whitlock, R., Granger, C. B., Connolly, S., & Healey, J. S. (2024). Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF. Journal of the American Heart Association, 13(17), 1–11. https://doi.org/10.1161/JAHA.123.034758

Chicago

Johnson, Linda S., Alexander P. Benz, Ashkan Shoamanesh, John W. Eikelboom, Michael Ezekowitz, Robert P. Giugliano, Lars Wallentin, et al. 2024. “Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.” Journal of the American Heart Association 13 (17): 1–11. doi:10.1161/JAHA.123.034758.